SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
30 Years of Pharmaceutical Cost-Utility Analyses
12 references·3 citing·35 second hop
30 Years of Pharmaceutical Cost-Utility Analyses (2009)30 Years of Pharmaceutical Cost-Utility A…National Health Spending In 2006: A Year Of Change For Prescription Drugs (2008)National Health Spending In 2…Bias in published cost effectiveness studies: systematic review (2006)Bias in published cost effect…Quality of Abstracts of Papers Reporting Original Cost-Effectiveness Analyses (2005)Quality of Abstracts of Paper…Methods for the Economic Evaluation of Health Care Programmes (2005)Methods for the Economic Eval…Growth and Quality of the Cost–Utility Literature, 1976–2001 (2005)Growth and Quality of the Cos…Cost-utility analyses of clinical preventive services (2000)Cost-utility analyses of clin…Users' Guides to the Medical Literature (1997)Users' Guides to the Medical …Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine (1996)Recommendations for reporting…Recommendations for Reporting Cost-effectiveness Analyses (1996)Recommendations for Reporting…Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Guidelines for authors and pe…Cost-Effectiveness in Health and Medicine (1996)Cost-Effectiveness in Health …Economic Analysis of Health Care Technology: A Report on Principles (1995)Economic Analysis of Health C…Comparison of Economic Evaluation Methods Across Low‐income, Middle‐income and High‐income Countries: What are the Differences and Why? (2016)Comparison of Economic Evalua…Is Individualized Medicine More Cost-Effective? A Systematic Review (2014)Is Individualized Medicine Mo…Comparative efficiency research (COMER): meta-analysis of cost-effectiveness studies (2014)Comparative efficiency resear…Methods for the economic evaluation of health care programmes (1987)Quality of life and pharmacoeconomics in clinical trials (1996)Inductive Teaching and Learning Methods: Definitions, Comparisons, and Research Bases (2006)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (2013)Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations (2022)The Existence of Publication Bias and Risk Factors for Its Occurrence (1990)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Conceptualizing a Model: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2 (2012)Estimating QALY Gains in Applied Studies: A Review of Cost-Utility Analyses Published in 2010 (2014)Corporate practices and health: a framework and mechanisms (2018)Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force (2022)The Measurement of Observer Agreement for Categorical Data (1977)Trends in the Measurement of Health Utilities in Published Cost-Utility Analyses (2006)Costing and Perspective in Published Cost-Effectiveness Analysis (2009)Decision Analysis and Cost-Effectiveness Analysis (2009)Utilities and Quality-Adjusted Life Years (1989)Cost-effectiveness league tables: More harm than good? (1993)In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health Care (1994)Introduction to health economics for physicians (2001)A cost-utility analysis of therapy for amblyopia (2002)EQ-SD: a measure of health status from the EuroQol Group (2001)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)The estimation of a preference-based measure of health from the SF-36 (2002)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)Community Care of North Carolina: Improving Care Through Community Health Networks (2008)Incentives for orphan drug research and development in the United States (2008)Prescription Drug Spending Trends In The United States: Looking Beyond The Turning Point (2008)Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report (2005)International survey on willingness‐to‐pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? (2009)The Quality of Reporting in Published Cost-Utility Analyses, 1976–1997 (2000)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement (2013)Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations (2022)
this work references cited by second hop

References

  • 2005Methods for the Economic Evaluation of Health Care Programmes13,647 cited
  • 1996Cost-Effectiveness in Health and Medicine7,192 cited
  • 1996Guidelines for authors and peer reviewers of economic submissions to the BMJ1,821 cited
  • 1996Recommendations for Reporting Cost-effectiveness Analyses1,146 cited
  • 1996Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine1,037 cited
  • 2006Bias in published cost effectiveness studies: systematic review383 cited
  • 1995Economic Analysis of Health Care Technology: A Report on Principles220 cited
  • 1997Users' Guides to the Medical Literature202 cited
  • 2008National Health Spending In 2006: A Year Of Change For Prescription Drugs167 cited
  • 2005Growth and Quality of the Cost–Utility Literature, 1976–2001161 cited
  • 2000Cost-utility analyses of clinical preventive services111 cited
  • 2005Quality of Abstracts of Papers Reporting Original Cost-Effectiveness Analyses35 cited

Cited by

  • 2014Is Individualized Medicine More Cost-Effective? A Systematic Review74 cited
  • 2016Comparison of Economic Evaluation Methods Across Low‐income, Middle‐income and High‐income Countries: What are the Differences and Why?69 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2014Comparative efficiency research (COMER): meta-analysis of cost-effectiveness studies68 cited